Developmental delay in fetal Aminopterin/methotrexate syndrome

Miguel Del Campo, Kenjiro Kosaki, F. C. Bennett, Kenneth L. Jones

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Maternal exposures to aminopterin and methotrexate have been associated with a pattern of malformation which includes prenatal-onset growth deficiency, severe lack of ossification of the calvarium, hypoplastic supraorbital ridges, small, low-set ears, micrognathia, and limb abnormalities. We report on a patient whose mother received methotrexate during the first trimester of pregnancy and who, in addition to the structural anomalies typical of maternal methotrexate exposure, has significant developmental delay. This is the third patient exposed to folic acid antagonists with mental retardation, providing further evidence that developmental delay is one feature of fetal aminopterin-methotrexate syndrome. Therefore, it is recommended that formal developmental testing be performed in all patients prenatally exposed to methotrexate.

Original languageEnglish
Pages (from-to)10-12
Number of pages3
JournalTeratology
Volume60
Issue number1
DOIs
Publication statusPublished - 1999
Externally publishedYes

Fingerprint

Aminopterin
Methotrexate
Maternal Exposure
Micrognathism
Folic Acid Antagonists
First Pregnancy Trimester
Osteogenesis
Skull
Intellectual Disability
Ear
Extremities
Mothers
Testing
Growth

ASJC Scopus subject areas

  • Developmental Biology
  • Embryology
  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Developmental delay in fetal Aminopterin/methotrexate syndrome. / Del Campo, Miguel; Kosaki, Kenjiro; Bennett, F. C.; Jones, Kenneth L.

In: Teratology, Vol. 60, No. 1, 1999, p. 10-12.

Research output: Contribution to journalArticle

Del Campo, Miguel ; Kosaki, Kenjiro ; Bennett, F. C. ; Jones, Kenneth L. / Developmental delay in fetal Aminopterin/methotrexate syndrome. In: Teratology. 1999 ; Vol. 60, No. 1. pp. 10-12.
@article{9f27628bd3dd4667a0af4d5f210db998,
title = "Developmental delay in fetal Aminopterin/methotrexate syndrome",
abstract = "Maternal exposures to aminopterin and methotrexate have been associated with a pattern of malformation which includes prenatal-onset growth deficiency, severe lack of ossification of the calvarium, hypoplastic supraorbital ridges, small, low-set ears, micrognathia, and limb abnormalities. We report on a patient whose mother received methotrexate during the first trimester of pregnancy and who, in addition to the structural anomalies typical of maternal methotrexate exposure, has significant developmental delay. This is the third patient exposed to folic acid antagonists with mental retardation, providing further evidence that developmental delay is one feature of fetal aminopterin-methotrexate syndrome. Therefore, it is recommended that formal developmental testing be performed in all patients prenatally exposed to methotrexate.",
author = "{Del Campo}, Miguel and Kenjiro Kosaki and Bennett, {F. C.} and Jones, {Kenneth L.}",
year = "1999",
doi = "10.1002/(SICI)1096-9926(199907)60:1<10::AID-TERA5>3.0.CO;2-H",
language = "English",
volume = "60",
pages = "10--12",
journal = "Teratology",
issn = "1542-0752",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Developmental delay in fetal Aminopterin/methotrexate syndrome

AU - Del Campo, Miguel

AU - Kosaki, Kenjiro

AU - Bennett, F. C.

AU - Jones, Kenneth L.

PY - 1999

Y1 - 1999

N2 - Maternal exposures to aminopterin and methotrexate have been associated with a pattern of malformation which includes prenatal-onset growth deficiency, severe lack of ossification of the calvarium, hypoplastic supraorbital ridges, small, low-set ears, micrognathia, and limb abnormalities. We report on a patient whose mother received methotrexate during the first trimester of pregnancy and who, in addition to the structural anomalies typical of maternal methotrexate exposure, has significant developmental delay. This is the third patient exposed to folic acid antagonists with mental retardation, providing further evidence that developmental delay is one feature of fetal aminopterin-methotrexate syndrome. Therefore, it is recommended that formal developmental testing be performed in all patients prenatally exposed to methotrexate.

AB - Maternal exposures to aminopterin and methotrexate have been associated with a pattern of malformation which includes prenatal-onset growth deficiency, severe lack of ossification of the calvarium, hypoplastic supraorbital ridges, small, low-set ears, micrognathia, and limb abnormalities. We report on a patient whose mother received methotrexate during the first trimester of pregnancy and who, in addition to the structural anomalies typical of maternal methotrexate exposure, has significant developmental delay. This is the third patient exposed to folic acid antagonists with mental retardation, providing further evidence that developmental delay is one feature of fetal aminopterin-methotrexate syndrome. Therefore, it is recommended that formal developmental testing be performed in all patients prenatally exposed to methotrexate.

UR - http://www.scopus.com/inward/record.url?scp=0032775962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032775962&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-9926(199907)60:1<10::AID-TERA5>3.0.CO;2-H

DO - 10.1002/(SICI)1096-9926(199907)60:1<10::AID-TERA5>3.0.CO;2-H

M3 - Article

C2 - 10413333

AN - SCOPUS:0032775962

VL - 60

SP - 10

EP - 12

JO - Teratology

JF - Teratology

SN - 1542-0752

IS - 1

ER -